TY - STD TI - WHO World Malaria Report 2015. Geneva: World Health Organization; 2015. ID - ref1 ER - TY - STD TI - Geneva, World Health Organization. Overview of malaria treatment. Geneva: World Health Organization; 2016. http://www.who.int/malaria/areas/treatment/overview/en/. Accessed 30 Oct 2016. UR - http://www.who.int/malaria/areas/treatment/overview/en/ ID - ref2 ER - TY - STD TI - Kaiser family foundation. The US government and global malaria efforts. 2016. http://kff.org/global-health-policy/fact-sheet/the-u-s-government-and-global-malaria/. Accessed 17 Jul 2016. UR - http://kff.org/global-health-policy/fact-sheet/the-u-s-government-and-global-malaria/ ID - ref3 ER - TY - STD TI - The Global Fund to fight AIDS tuberculosis and malaria financials. 2016. http://www.theglobalfund.org/en/financials/. UR - http://www.theglobalfund.org/en/financials/ ID - ref4 ER - TY - STD TI - WHO. Assessment of the safety of artemisinin compounds in pregnancy: report of two joint informal consultations convened in 2006. Geneva: World Health Organization; 2006. ID - ref5 ER - TY - JOUR AU - Dellicour, S. AU - Kuile, F. O. AU - Stergachis, A. PY - 2008 DA - 2008// TI - Pregnancy exposure registries for assessing antimalarial drug safety in pregnancy in malaria-endemic countries JO - PLoS Med. VL - 5 UR - https://doi.org/10.1371/journal.pmed.0050187 DO - 10.1371/journal.pmed.0050187 ID - Dellicour2008 ER - TY - JOUR AU - Clark, R. L. PY - 2009 DA - 2009// TI - Embryotoxicity of the artemisinin antimalarials and potential consequences for use in women in the first trimester JO - Reprod Toxicol VL - 28 UR - https://doi.org/10.1016/j.reprotox.2009.05.002 DO - 10.1016/j.reprotox.2009.05.002 ID - Clark2009 ER - TY - JOUR AU - Clark, R. L. AU - Arima, A. AU - Makori, N. AU - Nakata, Y. AU - Bernard, F. AU - Gristwood, W. PY - 2008 DA - 2008// TI - Artesunate: developmental toxicity and toxicokinetics in monkeys JO - Birth Defects Res B Dev Reprod Toxicol. VL - 83 UR - https://doi.org/10.1002/bdrb.20163 DO - 10.1002/bdrb.20163 ID - Clark2008 ER - TY - STD TI - European medicines agency. Eurartesim. 2013. http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/001199/human_med_001450.jsp&murl=menus/medicines/medicines.jsp&mid=WC0b01ac058001d124&jsenabled=true. Accessed 26 May 2015. UR - http://www.ema.europa.eu/ema/index.jsp%3fcurl%3dpages/medicines/human/medicines/001199/human_med_001450.jsp%26murl%3dmenus/medicines/medicines.jsp%26mid%3dWC0b01ac058001d124%26jsenabled%3dtrue ID - ref9 ER - TY - JOUR AU - Manning, J. AU - Vanachayangkul, P. AU - Lon, C. AU - Spring, M. AU - So, M. AU - Sea, D. PY - 2014 DA - 2014// TI - Randomized, double-blind, placebo-controlled clinical trial of a two-day regimen of dihydroartemisinin–piperaquine for malaria prevention halted for concern over prolonged corrected QT interval JO - Antimicrob Agents Chemother VL - 58 UR - https://doi.org/10.1128/AAC.02667-14 DO - 10.1128/AAC.02667-14 ID - Manning2014 ER - TY - JOUR AU - Baird, J. K. AU - Surjadjaja, C. PY - 2011 DA - 2011// TI - Consideration of ethics in primaquine therapy against malaria transmission JO - Trends Parasitol. VL - 27 UR - https://doi.org/10.1016/j.pt.2010.08.005 DO - 10.1016/j.pt.2010.08.005 ID - Baird2011 ER - TY - JOUR AU - Russom, M. AU - Tesfai, D. AU - Gebregiorgis, S. AU - Usman, A. AU - Mihreteab, S. AU - Bahta, I. PY - 2016 DA - 2016// TI - Artesunate/amodiaquine-induced acute extrapyramidal reactions in children and younger adults: case series assessment JO - Drug Saf VL - 39 UR - https://doi.org/10.1007/s40264-016-0429-6 DO - 10.1007/s40264-016-0429-6 ID - Russom2016 ER - TY - JOUR AU - Burger, R. J. AU - Eijk, A. M. AU - Bussink, M. AU - Hill, J. AU - Kuile, F. O. PY - 2016 DA - 2016// TI - Artemisinin-based combination therapy versus quinine or other combinations for treatment of uncomplicated Plasmodium falciparum malaria in the second and third trimester of pregnancy: a systematic review and meta-analysis JO - Open Forum Infect Dis. VL - 3 UR - https://doi.org/10.1093/ofid/ofv170 DO - 10.1093/ofid/ofv170 ID - Burger2016 ER - TY - JOUR AU - Achan, J. AU - Talisuna, A. O. AU - Erhart, A. AU - Yeka, A. AU - Tibenderana, J. K. AU - Baliraine, F. N. PY - 2011 DA - 2011// TI - Quinine, an old anti-malarial drug in a modern world: role in the treatment of malaria JO - Malar J. VL - 10 UR - https://doi.org/10.1186/1475-2875-10-144 DO - 10.1186/1475-2875-10-144 ID - Achan2011 ER - TY - JOUR AU - Nayyar, G. M. L. AU - Breman, J. G. AU - Newton, P. N. AU - Herrington, J. PY - 2012 DA - 2012// TI - Poor-quality antimalarial drugs in southeast Asia and sub-Saharan Africa JO - Lancet Infect Dis. VL - 12 UR - https://doi.org/10.1016/S1473-3099(12)70064-6 DO - 10.1016/S1473-3099(12)70064-6 ID - Nayyar2012 ER - TY - STD TI - WHO. Pharmacovigilance : ensuring the safe use of medicines. Geneva, World Health Organization, 2004. ID - ref16 ER - TY - JOUR AU - Bakare, N. AU - Edwards, I. R. AU - Stergachis, A. AU - Pal, S. AU - Holmes, C. B. AU - Duncombe, C. PY - 2011 DA - 2011// TI - Global pharmacovigilance for antiretroviral drugs: overcoming contrasting priorities JO - PLoS Med. VL - 8 UR - https://doi.org/10.1371/journal.pmed.1001054 DO - 10.1371/journal.pmed.1001054 ID - Bakare2011 ER - TY - STD TI - WHO. Minimum requirements for a functional pharmacovigilance system. Geneva: World Health Organization; 2010. ID - ref18 ER - TY - STD TI - Strengthening pharmaceutical systems. Safety of medicines in sub-Saharan Africa: assessment of pharmacovigilance systems and their performance. 2011. ID - ref19 ER - TY - JOUR AU - Ampadu, H. AU - Hoekman, J. AU - Bruin, M. AU - Pal, S. AU - Olsson, S. AU - Sartori, D. PY - 2016 DA - 2016// TI - Adverse drug reaction reporting in Africa and a comparison of individual case safety report characteristics between Africa and the rest of the world: analyses of spontaneous reports JO - Drug Saf VL - 39 UR - https://doi.org/10.1007/s40264-015-0387-4 DO - 10.1007/s40264-015-0387-4 ID - Ampadu2016 ER - TY - JOUR AU - Kuemmerle, A. AU - Dodoo, A. N. O. AU - Olsson, S. AU - Erps, J. AU - Burri, C. AU - Lalvani, P. S. PY - 2011 DA - 2011// TI - Assessment of global reporting of adverse drug reactions for anti-malarials, including artemisinin-based combination therapy, to the WHO Programme for International Drug Monitoring JO - Malar J. VL - 10 UR - https://doi.org/10.1186/1475-2875-10-57 DO - 10.1186/1475-2875-10-57 ID - Kuemmerle2011 ER - TY - JOUR AU - Olsson, S. AU - Pal, S. AU - Stergachis, A. AU - Couper, M. PY - 2010 DA - 2010// TI - Pharmacovigilance activities in 55 low- and middle-income countries JO - Drug Saf VL - 33 UR - https://doi.org/10.2165/11536390-000000000-00000 DO - 10.2165/11536390-000000000-00000 ID - Olsson2010 ER - TY - JOUR AU - Stergachis, A. AU - Bartlein, R. J. K. AU - Dodoo, A. AU - Nwokike, J. AU - Kachur, S. P. PY - 2010 DA - 2010// TI - A situational analysis of pharmacovigilance plans in the Global Fund Malaria and U.S. President’s Malaria Initiative proposals JO - Malar J. VL - 9 UR - https://doi.org/10.1186/1475-2875-9-148 DO - 10.1186/1475-2875-9-148 ID - Stergachis2010 ER - TY - CHAP AU - Nsubuga, P. AU - White, M. AU - Thacker, S. AU - Anderson, M. AU - Blount, S. AU - Broome, C. ED - Jamison, D. ED - Breman, J. ED - Measham, A. PY - 2006 DA - 2006// TI - Public health surveillance: a tool for targeting and monitoring interventions BT - Disease control priorities in developing countries PB - Oxford University Press CY - Washington DC ID - Nsubuga2006 ER - TY - STD TI - WHO. Health systems strengthening glossary. Geneva: World Health Organization; 2016. http://www.who.int/healthsystems/hss_glossary/en/index5.html. Accessed 14 Jun 2016. UR - http://www.who.int/healthsystems/hss_glossary/en/index5.html ID - ref25 ER - TY - JOUR AU - Mehta, U. AU - Clerk, C. AU - Allen, E. AU - Yore, M. AU - Sevene, E. AU - Singlovic, J. PY - 2012 DA - 2012// TI - Protocol for a drugs exposure pregnancy registry for implementation in resource-limited settings JO - BMC Pregnancy Childbirth. VL - 12 UR - https://doi.org/10.1186/1471-2393-12-89 DO - 10.1186/1471-2393-12-89 ID - Mehta2012 ER - TY - STD TI - The Global Fund to fight AIDS tuberculosis and malaria. The global fund strategy 2012–2016: investing for impact. 2016. http://www.theglobalfund.org/en/strategy/. Accessed 17 Jun 2016. UR - http://www.theglobalfund.org/en/strategy/ ID - ref27 ER - TY - STD TI - World Health Organization, UNAIDS. Technical guidance note for Global Fund HIV proposals pharmacovigilance for antiretroviral drugs. 2011. http://www.who.int/hiv/pub/tech_guidance_pharma.pdf. Accessed 14 Oct 2016. UR - http://www.who.int/hiv/pub/tech_guidance_pharma.pdf ID - ref28 ER -